ClinicalTrials.Veeva

Menu

Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories.

Becton, Dickinson and Company (BD) logo

Becton, Dickinson and Company (BD)

Status

Completed

Conditions

Analgesia
Anesthesia

Treatments

Device: BD NRFit™ Spinal Needles, BD NRFit™ Spinal Introducer Needles, and BD NRFit™ Syringes

Study type

Observational

Funder types

Industry

Identifiers

NCT05953363
MDS-21NRFit001

Details and patient eligibility

About

Multi-center, prospective, open label, single arm post-market study to assess the real-world safety and efficacy of BD NRFit™ Spinal Needles, BD NRFit™ Spinal Introducer Needles, and BD NRFit™ Syringes used in an on-market fashion.

Full description

This is a multi-center, prospective, open label, single arm post-market study that will enroll approximately 180 participants in order to have a minimum of 150 treated participants who will receive a spinal anesthesia procedure as part of their routine medical care. Participants will be followed from the time of enrollment for up to 10 days (± 3 days) post spinal anesthesia procedure for evidence of adverse events including Post Dural Puncture Headache (PDPH). This can be done via phone if the participant is discharged from the hospital. The site staff must take advantage of the time window of ± 3 days only when the 10-day post-procedure occurs during the weekends or holidays. Any adverse event or complication must be diagnosed and confirmed by a study physician.

A minimum of 50 participants for each of the two needle tip types (Quincke and Whitacre tip) will be enrolled in the study.

Enrollment

161 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Any patient, regardless of age or gender, for which the investigator has decided that a neuraxial procedure must be performed utilizing BD NRFit™ Spinal Needles, NRFit™ Spinal Introducer Needles, and NRFit™ Syringes as part of their routine medical care.
  2. Expected to be available for observation through the study period (10 days, ± 3 days, post procedure*).
  3. Able and willing to provide signed and dated informed consent or legal authorized representative (LAR) authorized to give consent on behalf of the participant (Note: Consent of guardian or parent may be required for participants under the age of 18 years; participant assent may be required as well).

Exclusion criteria

  1. Coagulopathy or bleeding disorder, where it is in the opinion of the investigator makes regional anesthetic of increased risk.
  2. Subjects with a history of neurological impairment of the trunk or lower extremities.
  3. Infection at the site of needle insertion.
  4. Previous spine surgery at the level involved in the study procedure.

Trial design

161 participants in 1 patient group

All participants
Description:
Participants who require a BD NRFit™ Spinal Needles, NRFit™ Spinal Introducer Needles, and NRFit™ Syringes as part of their routine medical care.
Treatment:
Device: BD NRFit™ Spinal Needles, BD NRFit™ Spinal Introducer Needles, and BD NRFit™ Syringes

Trial contacts and locations

5

Loading...

Central trial contact

Winfried Huesmann; Gloria Viti

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems